Ardelyx 将来の成長
Future 基準チェック /56
Ardelyx利益と収益がそれぞれ年間69.6%と25.6%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に2.9% 69.5%なると予測されています。
主要情報
69.6%
収益成長率
69.5%
EPS成長率
| Biotechs 収益成長 | 28.3% |
| 収益成長率 | 25.6% |
| 将来の株主資本利益率 | 2.9% |
| アナリストカバレッジ | Good |
| 最終更新日 | 11 Nov 2024 |
今後の成長に関する最新情報
Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts
Nov 03
Earnings Beat: Ardelyx, Inc. (NASDAQ:ARDX) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
Aug 04Ardelyx, Inc. (NASDAQ:ARDX) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
May 04Recent updates
Ardelyx Lost The Lawsuit, But The Kidney PATIENT Act Will Save It
Nov 24Ardelyx's Medicare Setback Casts Doubt On Long-Term Viability
Nov 14Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts
Nov 03Ardelyx, Inc.'s (NASDAQ:ARDX) Shares Lagging The Industry But So Is The Business
Oct 24Is Ardelyx (NASDAQ:ARDX) Weighed On By Its Debt Load?
Aug 25Party Time: Brokers Just Made Major Increases To Their Ardelyx, Inc. (NASDAQ:ARDX) Earnings Forecasts
Aug 07Ardelyx Faces Rising Challenges Despite Revenue Growth
Aug 05Earnings Beat: Ardelyx, Inc. (NASDAQ:ARDX) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
Aug 04Ardelyx: Increased Focus On Ibsrela Due To Xphozah's Uncertain Outlook
Jul 13Why Investors Shouldn't Be Surprised By Ardelyx, Inc.'s (NASDAQ:ARDX) 25% Share Price Plunge
Jul 05Ardelyx: Strong Execution, Fairly Valued
May 10Ardelyx, Inc. (NASDAQ:ARDX) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
May 04Ardelyx Stock: A Crowded Market Curbs The Enthusiasm (Rating Downgrade)
May 03Ardelyx, Inc.'s (NASDAQ:ARDX) Popularity With Investors Is Under Threat From Overpricing
Apr 17Ardelyx Shrugs Off 'Mixed' Q4 Earnings
Mar 13Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts
Feb 24Ardelyx Q4 Preview: Recent Bull Run May Pause While Market Digests 2024 Guidance
Feb 20Ardelyx's XPHOZAH Still An Afterthought To The Pros
Jan 31Ardelyx: FDA Approval For Xphozah Grants Further Sales Enhancement
Jan 10Ardelyx, Inc.'s (NASDAQ:ARDX) Business Is Yet to Catch Up With Its Share Price
Jan 04Despite Lacking Profits Ardelyx (NASDAQ:ARDX) Seems To Be On Top Of Its Debt
Dec 14Party Time: Brokers Just Made Major Increases To Their Ardelyx, Inc. (NASDAQ:ARDX) Earnings Forecasts
Aug 03Rock star Growth Puts Ardelyx (NASDAQ:ARDX) In A Position To Use Debt
Jul 31Pinning Down Ardelyx, Inc.'s (NASDAQ:ARDX) P/S Is Difficult Right Now
Apr 17Is Ardelyx (NASDAQ:ARDX) Using Debt Sensibly?
Mar 30Is Ardelyx (NASDAQ:ARDX) Using Debt Sensibly?
Dec 14What To Expect For Ardelyx In The Coming Month
Oct 18業績と収益の成長予測
| 日付 | 収益 | 収益 | フリー・キャッシュフロー | 営業活動によるキャッシュ | 平均アナリスト数 |
|---|---|---|---|---|---|
| 12/31/2026 | 515 | 113 | 160 | 165 | 9 |
| 12/31/2025 | 377 | -24 | 57 | 42 | 10 |
| 12/31/2024 | 326 | -42 | N/A | -21 | 10 |
| 9/30/2024 | 252 | -73 | -64 | -63 | N/A |
| 6/30/2024 | 210 | -65 | -86 | -85 | N/A |
| 3/31/2024 | 159 | -66 | -81 | -81 | N/A |
| 12/31/2023 | 124 | -66 | -90 | -90 | N/A |
| 9/30/2023 | 134 | -27 | -67 | -67 | N/A |
| 6/30/2023 | 83 | -56 | -71 | -71 | N/A |
| 3/31/2023 | 63 | -66 | -87 | -87 | N/A |
| 12/31/2022 | 52 | -67 | -70 | -70 | N/A |
| 9/30/2022 | 9 | -114 | -124 | -124 | N/A |
| 6/30/2022 | 5 | -135 | -133 | -133 | N/A |
| 3/31/2022 | 4 | -153 | -137 | -136 | N/A |
| 12/31/2021 | 10 | -158 | -154 | -153 | N/A |
| 9/30/2021 | 11 | -151 | -133 | -131 | N/A |
| 6/30/2021 | 12 | -125 | -118 | -116 | N/A |
| 3/31/2021 | 13 | -105 | -102 | -101 | N/A |
| 12/31/2020 | 8 | -94 | -82 | -81 | N/A |
| 9/30/2020 | 8 | -85 | -75 | -75 | N/A |
| 6/30/2020 | 8 | -91 | -76 | -76 | N/A |
| 3/31/2020 | 6 | -91 | -85 | -85 | N/A |
| 12/31/2019 | 5 | -95 | -77 | -76 | N/A |
| 9/30/2019 | 3 | -103 | -84 | -84 | N/A |
| 6/30/2019 | 0 | -104 | -91 | -90 | N/A |
| 3/31/2019 | 0 | -100 | -81 | -80 | N/A |
| 12/31/2018 | 3 | -91 | -71 | -70 | N/A |
| 9/30/2018 | 45 | -53 | -47 | -47 | N/A |
| 6/30/2018 | 44 | -50 | N/A | -39 | N/A |
| 3/31/2018 | 44 | -53 | N/A | -45 | N/A |
| 12/31/2017 | 42 | -64 | N/A | -65 | N/A |
| 9/30/2017 | N/A | -106 | N/A | -97 | N/A |
| 6/30/2017 | N/A | -114 | N/A | -102 | N/A |
| 3/31/2017 | N/A | -117 | N/A | -103 | N/A |
| 12/31/2016 | N/A | -112 | N/A | -93 | N/A |
| 9/30/2016 | N/A | -98 | N/A | -87 | N/A |
| 6/30/2016 | N/A | -87 | N/A | -75 | N/A |
| 3/31/2016 | 18 | -50 | N/A | -80 | N/A |
| 12/31/2015 | 24 | -30 | N/A | -72 | N/A |
| 9/30/2015 | 30 | -16 | N/A | -54 | N/A |
| 6/30/2015 | 38 | 2 | N/A | -48 | N/A |
| 3/31/2015 | 29 | -6 | N/A | 6 | N/A |
| 12/31/2014 | 32 | -3 | N/A | 13 | N/A |
| 9/30/2014 | 34 | -4 | N/A | 28 | N/A |
| 6/30/2014 | 33 | -5 | N/A | 34 | N/A |
| 3/31/2014 | 31 | -7 | N/A | 5 | N/A |
| 12/31/2013 | 29 | -7 | N/A | 2 | N/A |
アナリストによる今後の成長予測
収入対貯蓄率: ARDXは今後 3 年間で収益性が向上すると予測されており、これは 貯蓄率 ( 2.6% ) よりも高い成長率であると考えられます。
収益対市場: ARDX今後 3 年間で収益性が向上すると予想されており、これは市場平均を上回る成長と考えられます。
高成長収益: ARDX今後 3 年以内に収益を上げることが予想されます。
収益対市場: ARDXの収益 ( 25.6% ) US市場 ( 8.9% ) よりも速いペースで成長すると予測されています。
高い収益成長: ARDXの収益 ( 25.6% ) 20%よりも速いペースで成長すると予測されています。
一株当たり利益成長率予想
将来の株主資本利益率
将来のROE: ARDXの 自己資本利益率 は、3年後には低くなると予測されています ( 2.9 %)。